GILD vs PTCT · P/E 18, rev $7.80B vs rev $633.1M
Gilead Sciences Inc (GILD) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the GILD and PTCT stock pages for the full models.
Not investment advice.